We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$67.4M +$24.7M +237,427 +36%
AIM
2
ARK Investment Management
Florida
$57.7M -$13.8M -132,960 -15%
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$43.3M
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$38.6M +$8.15M +78,430 +18%
NAMA
5
Nikko Asset Management Americas
New York
$37.7M +$6.86M +66,002 +15%
BlackRock
6
BlackRock
New York
$31.2M +$8.75M +84,240 +25%
ABG
7
Ally Bridge Group
New York
$23.5M +$5.17M +49,740 +19%
FP
8
Flagship Pioneering
Massachusetts
$22M
Vanguard Group
9
Vanguard Group
Pennsylvania
$20.4M +$7.14M +68,772 +34%
SB
10
Samsara BioCapital
California
$14.8M
O
11
OrbiMed
New York
$13.7M +$2.86M +27,500 +18%
OFM
12
Omega Fund Management
Massachusetts
$11.7M
AG
13
Artal Group
Luxembourg
$7.67M +$2.86M +27,500 +37%
EC
14
EcoR1 Capital
California
$7.48M
RCM
15
RA Capital Management
Massachusetts
$6.73M +$9.35M +90,000 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$6.23M +$2.52M +24,291 +41%
State Street
17
State Street
Massachusetts
$5.95M +$711K +6,841 +9%
Citadel Advisors
18
Citadel Advisors
Florida
$5.22M +$6.17M +59,400 +570%
BBA
19
Baker Bros. Advisors
New York
$5.16M
JP Morgan Chase
20
JP Morgan Chase
New York
$4.97M -$748K -7,196 -10%
Goldman Sachs
21
Goldman Sachs
New York
$4.76M +$5.39M +51,904 +440%
Northern Trust
22
Northern Trust
Illinois
$3.89M +$708K +6,812 +15%
Morgan Stanley
23
Morgan Stanley
New York
$2.8M +$3.1M +29,834 +394%
Charles Schwab
24
Charles Schwab
California
$2.72M +$1.25M +12,022 +49%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$2.63M -$1.6M -15,391 -30%